Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression.
about
Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's diseaseAPPswe/PS1dE9 mice with cortical amyloid pathology show a reduced NAA/Cr ratio without apparent brain atrophy: A MRS and MRI studyAmyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatmentSynthesis, characterization, and preclinical validation of a PET radiopharmaceutical for interrogating Aβ (β-amyloid) plaques in Alzheimer's diseaseIncrease of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis.Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice.Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.Fluselenamyl: A Novel Benzoselenazole Derivative for PET Detection of Amyloid Plaques (Aβ) in Alzheimer's Disease.Modeling Alzheimer's disease with non-transgenic rat models.Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease.Accumulation of murine amyloid-β mimics early Alzheimer's disease.Mouse models of neurodegenerative disease: preclinical imaging and neurovascular component.Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease.
P2860
Q27309046-3E2F482B-DD52-45D7-969E-981A108E3E86Q33812308-10A910C2-95F9-42DD-9A6E-500B30CD0DB7Q35657401-3A058EA8-1CDD-4204-96C1-79ADCE420BF2Q35772537-DA831FF6-8A68-4C82-A314-E7DB323D1679Q36280558-78230F0D-A0B9-42FE-8DC8-6AD5308BB1C3Q36627314-0F93CF27-2F9C-4C31-AC54-0EBF70D467CCQ36691483-B14CD52E-32F3-4E57-8AF5-C2533C3B5637Q37386143-5A826F1E-5F85-4352-BF25-A5AB2F05BFA2Q38103295-C0DA487C-7D5F-417A-B040-17BC5E2FAB01Q41552181-8A1ACAD6-6A1A-4D63-96DA-A82929C45318Q46726629-A45861A2-7C5D-49DD-A851-3B7A7A0B36C1Q47998495-9F092814-369A-41D0-93BD-1884905CB68BQ55430546-9F305F47-892C-4020-93A3-CF9827510B0E
P2860
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Development of Alzheimer-disea ...... protein-transgene expression.
@ast
Development of Alzheimer-disea ...... protein-transgene expression.
@en
type
label
Development of Alzheimer-disea ...... protein-transgene expression.
@ast
Development of Alzheimer-disea ...... protein-transgene expression.
@en
prefLabel
Development of Alzheimer-disea ...... protein-transgene expression.
@ast
Development of Alzheimer-disea ...... protein-transgene expression.
@en
P50
P921
P1476
Development of Alzheimer-disea ...... r protein-transgene expression
@en
P2093
Johannes Thome
Stefan J Teipel
P304
P356
10.1016/J.PNEUROBIO.2011.05.004
P577
2011-05-12T00:00:00Z